Robert Damoiseaux

Robert D Damoiseaux

Adjunct Professor, Molecular and Medical Pharmacology, University of California Los Angeles


Mailing Address:
Mail Code: 148906
2805 Molecular Sciences Bldg.
Los Angeles, CA 90095

Work Address:
California NanoSystems Institute
570 Westwood Plaza
Bldg 114
Los Angeles, CA 90095

Office Phone Number:


Director, Molecular Screening Shared Resource (MSSR)
Member, Molecular Pharmacology GPB Home Area


Robert Damoiseaux, Ph.D. is a High Throughput Screening (HTS) expert and a professor in the Department of Molecular and Medical Pharmacology of the David Geffen School of Medicine. His research interests focus on the development of novel HTS technologies. He also directs the Molecular Screening Shared Resource (MSSR) which is a cutting edge facility involved in research projects with, among others, UCLA, Caltech, and the biotech and pharmaceutical industries. He received his PhD at the University of Lausanne under Dr. Kai Johnsson (currently director at the Max Planck Institute for Medical Research, Munich) and then joined the Institute for Functional Genomics (GNF, Novartis) where he was in charge of the development of the next generation assay platform for proteases. He authored over 100 manuscripts and patents on high throughput screening and synthesis, was recognized as expert author in Wiley’s Development of Therapeutic Agents Handbook and is also an editor for Springers Current Protocols in Molecular biology. He is also member of the NIH study section and special emphasis panel reviewing high throughput screening grants. His expertise in high-through-put screening and the use of novel technologies brings him into demand for scientific collaborations and consulting for both academia and industry.